Abstract:Abstract Background Organ transplantation is predicted to increase as life expectancy and the incidence of chronic diseases rises. Regenerative medicine-inspired technologies challenge the efficacy of the current allograft transplantation model. Methods A literature review was conducted using the PubMed interface of MEDLINE from the National Library of Medicine. Results were examined for relevance to innovations of organ bioengineering to inform analysis of advances in regenerative medicine affecting organ transplantation. Data reports from the Scientific Registry of Transplant Recipient and Organ Procurement Transplantation Network from 2008 to 2019 of kidney, pancreas, liver, heart, lung and intestine transplants performed, and patients currently on waiting lists for respective organs, were reviewed to demonstrate the shortage and need for transplantable organs. Results Regenerative medicine technologies aim to repair and regenerate poorly functioning organs. One goal is to achieve an immunosuppression-free state to improve quality of life, reduce complications and toxicities, and eliminate the cost of lifelong antirejection therapy. Innovative strategies include decellularization to fabricate acellular scaffolds that will be used as a template for organ manufacturing, three-dimensional printing and interspecies blastocyst complementation. Induced pluripotent stem cells are an innovation in stem cell technology which mitigate both the ethical concerns associated with embryonic stem cells and the limitation of other progenitor cells, which lack pluripotency. Regenerative medicine technologies hold promise in a wide array of fields and applications, such as promoting regeneration of native cell lines, growth of new tissue or organs, modelling of disease states, and augmenting the viability of existing ex vivo transplanted organs. Conclusion The future of organ bioengineering relies on furthering understanding of organogenesis, in vivo regeneration, regenerative immunology and long-term monitoring of implanted bioengineered organs.

European Society for Organ Transplantation Congress in 2011

Chinese Efforts to Pursue Effective Communication with Family of Potential Organ and Tissue Donor

Extended criteria donor reconditioning and functional improvement in the viewshed of machine perfusion plus

International issues in transplantation. Setting the scene and flagging the most urgent and controversial issues

What's Hot, What's New From the 2016 American Transplant Congress

Machine perfusion preservation highlights from the Congress of the European Society of Organ Transplantation 2023

What's hot, what's new: Report from the American Transplant Congress 2017

MicroRNA-27 a inhibitors alone or in combination with perifosine suppress the growth of gastric cancer cells

Analysis of Research Hotspot Concerning Publications on Organ Transplantation

Joining Forces in Basic Science: ITS Meeting 2.0

What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2023? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society

What's hot, what's new in basic science: report from the American Transplant Congress 2015

Regulation of lambda prophage excision by the transcriptional state of DNA.

Machine perfusion organ preservation: Highlights from the American Transplant Congress 2023

Current progress in xenotransplantation and organ bioengineering

Scientific and standard promotion of organ donation and transplantation in China

Challenges and Opportunities of Liver Xenotransplantation

Regenerative medicine, organ bioengineering and transplantation

Deceased donor organ retrieval: impact on cardiovascular research

Heart transplantation: advances in expanding the donor pool and xenotransplantation

Organ Transplantation in Rodents: Novel Applications of Long-Established Methods